Gouvernement du Québec
Régie de l’assurance maladie

Important information

The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

4860 results found.

Example of search result explained

Wezlana

Exceptional medication
  • Active ingredient(s):
    ustekinumab (plaque psoriasis children)
  • Manufactured by:
    Amgen Canada Inc. (Amgen)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution syringe 45 mg/0.5 mL DIN : 99114450
    • Subcutaneous Injectable Solution syringe 90 mg/1 mL DIN : 99114448
    • Subcutaneous Injectable Solution 45 mg/0.5 mL DIN : 99114447
    • Subcutaneous Injectable Solution (pen) 45 mg/0.5 mL DIN : 99114445
    • Subcutaneous Injectable Solution (pen) 90 mg/1 mL DIN : 99114446

Hulio (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab
  • Manufactured by:
    Biocon Biologics Canada Inc. (Biocon)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 50 mg/mL (0,4 mL) DIN : 2502380
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 2502399

Hulio (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab
  • Manufactured by:
    Biocon Biologics Canada Inc. (Biocon)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 2502402

Hulio (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab (ulcerative colitis-children)
  • Manufactured by:
    Biocon Biologics Canada Inc. (Biocon)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 50 mg/mL (0,4 mL) DIN : 99114162
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114161

Hulio (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab (ulcerative colitis-children)
  • Manufactured by:
    Biocon Biologics Canada Inc. (Biocon)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114163

Hulio (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab (hidradenitis suppurativa)
  • Manufactured by:
    Biocon Biologics Canada Inc. (Biocon)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 50 mg/mL (0,4 mL) DIN : 99114041
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114042

Hulio (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab (hidradenitis suppurativa)
  • Manufactured by:
    Biocon Biologics Canada Inc. (Biocon)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114043

Hulio (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab (uveitis)
  • Manufactured by:
    Biocon Biologics Canada Inc. (Biocon)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 50 mg/mL (0,4 mL) DIN : 99114104
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114105

Hulio (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab (uveitis)
  • Manufactured by:
    Biocon Biologics Canada Inc. (Biocon)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114106

Bimzelx

Exceptional medication
  • Active ingredient(s):
    bimekizumab (psoriatic arthritis and ankylosing spondylitis )
  • Manufactured by:
    U.C.B. Pharma Canada Inc. (U.C.B.)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution syringe 160 mg/mL (1 mL) DIN : 99114458
    • Subcutaneous Injectable Solution (pen) 160 mg/mL (1 mL) DIN : 99114459
Page 139 of 486

How did we do?

Was the information on this page useful to you?
Do not include any personal information. You will not receive any reply.